| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Solit
|
Doctor patient researcher subject |
1
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2010-04-01 | N/A | Patient number 45's cancer was confirmed gone. | Sloan-Kettering | View |
| 2010-01-01 | N/A | Patient number 45 enrolled in the everolimus study at Sloan-Kettering. | Sloan-Kettering | View |
A magazine article page (p. 36) titled 'An Unlikely Cure Signals New Hope for Cancer' by Kat McGowan. It details a case study at Memorial Sloan-Kettering where a 73-year-old bladder cancer patient ('Patient 45') had a miraculous recovery using the drug everolimus in 2010. The article highlights Dr. David Solit's work in sequencing the patient's genome to identify the mutations responsible for the cure. The document includes a Bates stamp 'HOUSE_OVERSIGHT_015496', indicating it is part of a congressional investigation file.
This document is an educational worksheet from Nautilus (Nautil.us) titled 'Text Sets.' It contains reading comprehension questions, discussion topics, and activities related to genetics, orphan diseases, mutations (specifically mentioning calpain 3), and pharmaceutical development. It aligns the content with high school science curriculum standards (HS-LS1-1, HS-LS3-2, HS-LS3-3). The document bears the Bates stamp 'HOUSE_OVERSIGHT_015489', suggesting it was collected as part of a House Oversight Committee investigation, likely related to Jeffrey Epstein's funding of scientific organizations or publications.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity